Literature DB >> 16526226

[Diagnostic value of certain methods for isolation of Mycobacterium tuberculosis in children with suspected pulmonary tuberculosis].

Slobodanka Petrović1.   

Abstract

INTRODUCTION: The aim of this study was to find out if bronchoalveolar lavage (BL) is better than gastric lavage (GL) or sputum (SP) examination for isolation of Mycobacterium tuberculosis in childhood pulmonary tuberculosis.
MATERIAL AND METHODS: The study included a group of 30 children with suspected pulmonary tuberculosis, aged 6 months to 18 years. Gastric lavage was done on 4 consecutive mornings after overnight fast. Sputum was examined in 12 patients older than 10 years, (4 consecutive samples). BL was performed on the same day as the last GL and SP, using a rigid bronchoscope. Specimens were examined for the existence of BL acid fast bacilli (AFB) and culture for Mycobacterium tb.
RESULTS: Out of 30 cases, Mycobacterium tb was grown in 13 BL sampies (43.33%), and in 10 GL samples from the same patients (33.33%). Comparative analysis of microbiological samples of sputum and bronchoalveolar lavage fluid in 12 children showed that 6 patients had SP+ cultures and 6 patients had SP-cultures of Mycobacterium tb. All SP+ patients where also BL+, but 1 SP- patient was BL+. Smear examination of BL fluid samples was positive for AFB in 10 patients with positive cultures for Mycobacterium tb.
CONCLUSION: The results of our study indicate that BL examination is better than GL and SP examination for bacteriological diagnosis of childhood tuberculosis.

Entities:  

Mesh:

Year:  2005        PMID: 16526226     DOI: 10.2298/mpns0506231p

Source DB:  PubMed          Journal:  Med Pregl        ISSN: 0025-8105


  1 in total

1.  A Comprehensive Evaluation of a Loop-Mediated Isothermal Amplification Assay for the Diagnosis of Pulmonary Tuberculosis in Children Using Bronchoalveolar Lavage Fluid.

Authors:  Lichao Fan; Bo Guan; Moxin Cheng; Chang Liu; Yao Tian; Ran Li; Yu Chen
Journal:  Infect Drug Resist       Date:  2022-03-10       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.